CClinicalTrials.gg
RecruitingNCT05958654DETECT-RPCUpdated Jun 13, 2025

DETECT-RPC Universal EM Screening

An interventional study of Detection of Elder mistreatment Through Emergency Care Technicians-Revised for Primary Care (DETECT-RPC) screening tool in Elder Abuse and Elder Mistreatment, sponsored by The University of Texas Health Science Center, Houston. Recruiting at 7 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-06-13.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Screening

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to evaluate whether the use of the Detection of Elder Mistreatment Through Emergency Care Technicians-Revised for Primary Care (DETECT-RPC) screening tool increases the average reporting of elder mistreatment (EM) by homebased primary care (HBPC) clinicians.

02

Conditions studied

  • Elder Abuse
  • Elder Mistreatment

Keywords

  • Elder Mistreatment
03

In context

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 880 studies on the registry; 209 are open to participants now.

Of its 170 completed or terminated interventional studies of FDA-regulated products, 140 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria (Clinicians):

  • Clinician who actively provides home-based primary care (HBPC) to patients enrolled in one of our partner home-based primary care programs at least part time.

Exclusion Criteria (Clinicians):

  • HBPC Clinicians must be a physician, nurse practitioner, or physician assistant who actively provides home-based primary care to patients enrolled at a partner site HBPC at least part time

Inclusion Criteria (patients):

  • in home-based primary care
  • 60 years or older
  • seen by a clinician participating in the study

Exclusion Criteria (patients)

  • Must be aged 60 and older, enrolled in a site-specific partner HBPC and treated in their primary residence
05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
43 participants (estimated)

Study arms

  • Experimental
    with DETECT-RPC screening tool

    Behavioral: Detection of Elder mistreatment Through Emergency Care Technicians-Revised for Primary Care (DETECT-RPC) screening tool

  • No intervention
    without DETECT-RPC screening tool

Interventions

  • BehavioralDetection of Elder mistreatment Through Emergency Care Technicians-Revised for Primary Care (DETECT-RPC) screening tool

    DETECT is an elder mistreatment (EM) screening tool created for medics in the Fort Worth Texas area to use when responding to the homes of older adults, enabling them to screen for signs of elder mistreatment. DETECT-RPC is the adapted version of this tool designed specifically for use by home-based primary care (HBPC) clinicians. The DETECT-RPC tool is designed to: 1. Be brief and easy to use. 2. Focus on the clinician's direct observations of the older adult and their physical and social environment. 3. Provide clear guidance on reporting suspected EM. 4. Integrate seamlessly into existing procedures and medical charting systems.

    Also known as: DETECT-RPC screening tool

06

What researchers measure

Primary outcomes

  1. number of reports of EM

    Data will be collected on the number of reports of EM made by clinicians to the appropriate authorities \[for example, adult protective services (APS)\]

    Time frame: from randomization to termination of data collection (3 years)

  2. Mortality

    Mortality among patients will be assessed among patients enrolled in the partner home-based primary care programs.

    Time frame: from randomization to termination of data collection (3 years)

07

Study locations

7 of 7 sites recruiting
  • University of Alabama at Birmingham
    Birmingham, Alabama 35294, United States
    Recruiting
  • University of California San Francisco
    San Francisco, California 94143, United States
    Recruiting
  • John Hopkins University Medicine International
    Baltimore, Maryland 21218, United States
    Recruiting
  • University of Texas Southwestern Medical Center
    Dallas, Texas 75390, United States
    Recruiting
  • Baylor College of Medicine
    Houston, Texas 77030, United States
    Recruiting
  • The University of Texas health Science Center at Houston( LBJ House Calls Program)
    Houston, Texas 77030, United States
    Recruiting
  • The University of Texas Health Science Center at Houston( UT Physicians House Calls Program)
    Houston, Texas 77030, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 13, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05958654
Lead sponsor
The University of Texas Health Science Center, Houston
Collaborators
National Institute on Aging (NIA)
Responsible party
Michael Bradley Cannell (Associate Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Jul 24, 2023
Start date
Feb 18, 2025
Primary completion
Aug 31, 2028 (estimated)
Completion
Aug 31, 2029 (estimated)
Last update
Jun 13, 2025

Study contacts

Michael B Cannell, PhD,MPH
Contact
Michael.B.Cannell@uth.tmc.edu
972-546-2925
James S Barnes
Contact
James.S.Barnes@uth.tmc.edu
972-546-2934
Michael B Cannell, PhD,MPH
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion